Clinical Trial Update: GW406381 In Patients With Peripheral Nerve Injury [Phase 1]

View source ↗

Summary

A Phase 1 trial of GW406381 in patients with peripheral nerve injury has completed. The study examined pain-related conditions such as hyperalgesia and neuralgi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Neuropathic Pain
• Peripheral Nerve Injury

Drugs mentioned

• GW406381

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hyperalgesia, Neurodynia | Phase 1 | Status: COMPLETED